首页> 外文期刊>Journal of organ dysfunction >Human fetal hepatocyte behavior in dynamic 3D perfusion culture bioreactors
【24h】

Human fetal hepatocyte behavior in dynamic 3D perfusion culture bioreactors

机译:动态3D灌注培养生物反应器中人胎儿肝细胞的行为

获取原文
获取原文并翻译 | 示例
       

摘要

Extracorporeal liver support has been used to bridge patients with acute liver failure to orthotopic liver transplantation. However, the limited functional sustainability of adult hepatocytes in bioreactors mandates the investigation of alternate cell sources. Owing to their plasticity, fetal hepatocytes are an attractive source for use in bioartificial liver devices. Establishing a renewable in vitro source of fetal hepatocytes would also be of interest with regard to possible hepatic cell transplantation studies. Herein, we discuss the use of single-cell suspensions of murine and human fetal liver cells in a dynamic 3D perfusion bioreactor based on artificial capillary beds which form four interwoven compartments. Histology showed neo-tissue formation in between the artificial capillaries. Further immunohistochemical characterization using proliferating cell nuclear antigen and Ki-67 demonstrated ongoing cell proliferation and survival. These tissues were comprised of albumin-positive hepatocytes, while fewer cells were positive for α-fetoprotein, CK-19, and c-kit, indicating a progenitor compartment. Cells expressing mesenchymal markers, including endothelial and stellate cells, were also observed. While the results of human and murine studies were comparable there were still some dissimilarities which support species differences and perhaps initial viability issues with human fetal hepatocytes. Thus, our preliminary results on human fetal liver cells, supported by experimental data using murine fetal liver cells, suggest that the former have distinct advantages over adult hepatocytes for possible studies in regenerative medicine and can be maintained in vitro over prolonged periods, due to maintenance of the tissue-replenishing progenitor pool.
机译:体外肝支持已被用来将急性肝衰竭患者与原位肝移植联系起来。然而,成年肝细胞在生物反应器中功能上的可持续性有限,要求对其他细胞来源进行研究。由于其可塑性,胎儿肝细胞是用于生物人工肝装置的有吸引力的来源。关于可能的肝细胞移植研究,建立胎儿肝细胞的可再生体外来源也将是令人感兴趣的。在这里,我们讨论了在基于人工毛细血管床的动态3D灌注生物反应器中使用鼠细胞和人胎儿肝细胞的单细胞悬液,该细胞形成了四个交织的隔室。组织学显示在人造毛细血管之间形成新组织。使用增殖细胞核抗原和Ki-67的进一步免疫组织化学表征证明了正在进行的细胞增殖和存活。这些组织由白蛋白阳性的肝细胞组成,而α-甲胎蛋白,CK-19和c-kit阳性的细胞较少,表明存在祖细胞。还观察到了表达间充质标志物的细胞,包括内皮细胞和星状细胞。尽管人类和鼠类研究的结果具有可比性,但仍然存在一些差异,这些差异支持物种差异以及人类胎儿肝细胞最初的生存能力问题。因此,我们关于人类胎儿肝细胞的初步结果,得到使用鼠类胎儿肝细胞的实验数据的支持,表明前者在再生医学方面的研究可能比成年肝细胞具有明显优势,并且由于维持作用而可以在体外长期维持补充组织的祖细胞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号